Page last updated: 2024-08-24

1-aminooxy-3-aminopropane and Leishmaniasis, Visceral

1-aminooxy-3-aminopropane has been researched along with Leishmaniasis, Visceral in 2 studies

*Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chatterjee, M; Heby, O; Khomutov, AR; Madhubala, R; Mukherjee, A; Persson, L; Singh, S1
Khomutov, MA; Kochetkov, SN; Madhubala, R; Mandal, S; Saxena, N; Simonian, AR; Vepsalainen, J; Weisell, J1

Other Studies

2 other study(ies) available for 1-aminooxy-3-aminopropane and Leishmaniasis, Visceral

ArticleYear
Antileishmanial effect of 3-aminooxy-1-aminopropane is due to polyamine depletion.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2

    Topics: Animals; Drug Resistance; Leishmania donovani; Leishmaniasis, Visceral; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Propylamines; Transfection

2007
Novel convenient synthesis of biologically active esters of hydroxylamine.
    Amino acids, 2010, Volume: 38, Issue:2

    Topics: Antiprotozoal Agents; Esters; Humans; Hydroxylamine; Leishmania donovani; Leishmaniasis, Visceral; Propylamines

2010